Compare · ETN vs MLAB
ETN vs MLAB
Side-by-side comparison of Eaton Corporation PLC (ETN) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- ETN operates in Technology, while MLAB operates in Industrials - the two are in different parts of the market.
- ETN is the larger of the two at $158.93B, about 223.0x MLAB ($712.6M).
- ETN has been more active in the news (14 items in the past 4 weeks vs 13 for MLAB).
- ETN has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- Eaton Corporation PLC
- Mesa Laboratories Inc.
- Price
- $416.92+1.88%
- $125.94-1.71%
- Market cap
- $158.93B
- $712.6M
- 1M return
- -
- +25.06%
- 1Y return
- -
- +81.44%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 14
- 13
- Recent ratings
- 25
- 3
Eaton Corporation PLC
Eaton Corporation plc operates as a power management company. Its Electrical Americas and Electrical Global segment provides electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality products, wiring devices, circuit protection products, utility power distribution products, power reliability equipment, and services in North and South America, as well as hazardous duty electrical, emergency lighting, fire detection, explosion-proof instrumentation, and structural support systems internationally. The company's Hydraulics segment provides pumps, motors, and hydraulic power units; valves, cylinders, and electronic controls; industrial and hydraulic hoses, fittings, assemblies, thermoplastic hose and tubing products, couplings, connectors, and assembly equipment; and industrial drums and disc brakes. Its Aerospace segment offers pumps, motors, hydraulic power units, hoses and fittings, and electro-hydraulic pumps; valves, cylinders, electronic controls, electromechanical actuators, sensors, aircraft flap and slat systems, and nose wheel steering systems; thermoplastic tubing products, fittings, adapters, couplings, and sealing and ducting products; fuel pumps, sensors, valves, and adapters and regulators; and wiring connectors and cables, as well as hydraulic and bag filters, strainers and cartridges, and golf grips. The company's Vehicle segment offers transmissions, clutches, hybrid power systems, superchargers, engine valves and valve actuation systems, cylinder heads, locking and limited slip differentials, transmission controls, and fuel vapor components for the vehicle industry. Its eMobility segment provides voltage inverters, converters, fuses, onboard chargers, circuit protection units, vehicle controls, power distribution systems, fuel tank isolation valves, and commercial vehicle hybrid systems. The company was founded in 1916 and is based in Dublin, Ireland.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest ETN
- How Power Constraints Are Shaping the Future of AI Data Center Growth
- Robert W. Baird initiated coverage on Eaton with a new price target
- Eaton Supports Emergency Readiness and Energy Resilience for 35 California Healthcare Facilities
- SEC Form 3 filed by new insider Black Shawn M
- Eaton Names Shawn Black President, Aerospace
- Trane Technologies and Eaton Collaborate on Industry-First Reference Design to Help Boost AI Data Center Efficiency and Cut Installation Costs
- Director Johnson Gerald bought $92,162 worth of Ordinary Shares (200 units at $460.81), increasing direct ownership by 12% to 1,829 units (SEC Form 4)
- Officer Monesmith Heath B. exercised 20,041 units of Ordinary Shares at a strike of $132.72, covered exercise/tax liability with 653 units of Ordinary Shares and sold $8,261,224 worth of Ordinary Shares (18,036 units at $458.04), increasing direct ownership by 3% to 51,174 units (SEC Form 4)
- SEC Form 144 filed by Eaton Corporation PLC
- Officer Yelton Michael exercised 658 units of Ordinary Shares at a strike of $151.76 and covered exercise/tax liability with 221 units of Ordinary Shares, increasing direct ownership by 21% to 2,533 units (SEC Form 4)
Latest MLAB
- Director Capone Mark Christopher converted options into 2,784 shares, increasing direct ownership by 81% to 6,213 units (SEC Form 4)
- Director Alltoft Jennifer Sadie converted options into 2,784 shares, increasing direct ownership by 57% to 7,662 units (SEC Form 4)
- Director Ladiwala Shiraz Shabanali converted options into 3,810 shares, increasing direct ownership by 45% to 12,333 units (SEC Form 4)
- Director Hall Shannon converted options into 2,784 shares, increasing direct ownership by 66% to 6,973 units (SEC Form 4)
- Director Tripeny R Tony converted options into 2,784 shares, increasing direct ownership by 44% to 9,082 units (SEC Form 4)
- Director Sullivan John James converted options into 2,784 shares, increasing direct ownership by 16% to 20,618 units (SEC Form 4)
- Director Sullivan John James sold $800,090 worth of shares (7,093 units at $112.80), decreasing direct ownership by 28% to 17,834 units (SEC Form 4)
- President and CEO Kadia Siddhartha bought $800,090 worth of shares (7,093 units at $112.80) (SEC Form 4)
- Director Tripeny R Tony bought $102,321 worth of shares (900 units at $113.69), increasing direct ownership by 17% to 6,298 units (SEC Form 4)
- SEC Form 10-Q filed by Mesa Laboratories Inc.